presenting with non-ST-segment acute coronary syndromes (NSTEACS) in the largescale ACUITY trial. Methods: ACUITY was as an international randomized trial of different antithrombotic and antiplatelet regimens in 13,819 patients with moderate and high-risk NSTEACS. Revascularization strategy was per discretion of the local clinical team. We compared patients with a history of prior CABG by revascularization strategy (CABG vs. PCI). Results: A total of 1,433 NSTEACS patients with previous CABG underwent revascularization in the ACUITY trial. Of them, 1,360 (94.9%) underwent PCI and 73 (5.1%) underwent redo CABG. Redo CABG was associated with greater rates of postprocedural acute kidney injury (AKI) (30.0% vs. 10.8%, p<0.0001) and 30-day major bleeding (63.1% vs. 6.6%, p<0.0001) compared with PCI. CABG (vs. PCI) was an independent predictor of AKI and major bleeding. At 1-year, redo CABG rather than PCI was associated with higher rates of MI (21.2%% vs. 13.5%, p¼0.04), mortality (13.8% vs. 5.4%, p¼0.0007), and MACE (39.2% vs. 27.8%, p ¼0.007), whereas ischemia-driven target vessel revascularization was more common in the PCI group (12.4% vs. 1.7%, p¼0.02). By multivariable analysis, redo CABG was independently associated with 1-year mortality and MACE (Table) . Conclusions: Patients with prior CABG presenting with NSTEACS who were managed with redo CABG rather than PCI had higher rates of short-and long-term adverse events. While not a randomized trial, these data suggest that PCI should be the favored procedure in the NSTEACS patient with prior CABG in whom revascularization is required. Background: Acute hyperglycemia on admission increases risk of cardiac events after ST-elevated myocardial infarction(STEMI) patients. However, it still remains unclear whether acute glycemic variability has the important prognostic significance. Therefore, this study aimed to evaluate the relationship between cardiac events and the variability of glucose levels by a continuous glucose monitoring system (CGMS).
Toho University Ohashi Medical Center, Tokyo, Japan
Background: Acute hyperglycemia on admission increases risk of cardiac events after ST-elevated myocardial infarction(STEMI) patients. However, it still remains unclear whether acute glycemic variability has the important prognostic significance. Therefore, this study aimed to evaluate the relationship between cardiac events and the variability of glucose levels by a continuous glucose monitoring system (CGMS).
Methods: This prospective study enrolled 40 patients (age 70AE14 years, 78 % male) with STEMI. All patients were inserted CGMS on admission and were measured at least 48-hours. CGMS provide with glycemic excursion displayed at 5-minutes intervals, 576 points during 48 hours. Primary end points were the incidence of major adverse cardiac events (MACE) at 1 year, including cardiac death, myocardial infarction, and heart failure. Results: We found 3 patterns as the change of glucose wave (figure). The three patterns were defined persistent hyperglycemic pattern (PHP), intermittent hyperglycemic pattern (IHP), normal glycemic pattern (NGP). Significant differences were observed regarding the mean amplitude of glycemic excursions among 3 patterns (120AE61mg/dl, 93AE41mg/dl, and 45AE16mg/dl in PHP, IHP, and NGP, respectively p¼0.0004). The MACE incidence rates were 75%, 31%, and 5% in PHP, IHP, and NGP, respectively, (p¼0.17).
Conclusions: A significant relationship was observed between cardiac events and the variability of hyperglycemic levels during 48 hours after coronary interventions.
Patients with PHP, even IHP, were associated with an increased risk of cardiac events.
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